Fundraising FoxAnserBio
2 known investors
Find your way into AnserBio
Sign up to see every warm intro you have to AnserBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AnserBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies. The team combines expertise in immuno-oncology, cell therapy, and translational R&D.
Founders & leadership
LV
Lana VolokhCo-founder
AT
Alex TendlerCo-founder
YT
Yevgeny TendlerCSO
Investors · 2
Frequently asked questions
- What does AnserBio do?
- Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies. The team combines expertise in immuno-oncology, cell therapy, and translational R&D.
- Who founded AnserBio?
- AnserBio was founded by Lana Volokh, Alex Tendler.
- Who are AnserBio's investors?
- AnserBio's investors include Peregrine Ventures, Israel Biotech Fund.